BioCentury | Feb 25, 2008
Company News

Genstruct, Pfizer deal

...Under a new a master research agreement with Pfizer, Genstruct will conduct a systems biology analysis...
...collaborated on more than 20 projects in cancer, vascular injury, cardiovascular diseases and metabolic diseases. Genstruct...
...biomarkers resulting from the master agreement, which covers prior collaborations. Financial terms were not disclosed. Genstruct Inc....
BioCentury | Jul 30, 2007
Company News

Genstruct management update

Genstruct Inc. , Cambridge, Mass Business: Combinatorial biology, Bioinformatics Hired: Christopher Thomajan as CFO, formerly CFO of Impress Software Inc.; he replaces Jim Melanson, who departed WIR Staff...
BioCentury | Apr 2, 2007
Company News

Genstruct management update

Genstruct Inc. , Cambridge, Mass. Business: Combinatorial biology, Bioinformatics Hired: Christian Reich as VP of scientific research, formerly a physician WIR Staff...
BioCentury | Aug 14, 2006
Company News

Genstruct, GlaxoSmithKline deal

...The companies extended for an undisclosed amount of time a 2005 deal in which Genstruct is...
...where the analysis will be extended into additional biological systems. Further terms were not disclosed. Genstruct Inc....
BioCentury | Aug 22, 2005
Company News

Genstruct, Pfizer deal

...Genstruct received an undisclosed first milestone payment from PFE under a 2004 deal to use Genstruct's...
...to identify biomarkers, improve leads and optimize clinical trial design (see BioCentury, Nov. 15, 2004). Genstruct Inc....
BioCentury | Jun 27, 2005
Company News

Genstruct scientific advisory board update

Genstruct Inc. , Cambridge, Mass. Business: Combinatorial biology, Bioinformatics Appointed: Alan Williamson, retired professor of biochemistry at the University of Glasgow WIR Staff...
BioCentury | Feb 21, 2005
Company News

Genstruct board of directors update

Genstruct Inc. , Cambridge, Mass. Business: Bioinformatics Appointed: Michael Pavia, former CTO of Millennium Pharmaceuticals Inc. WIR Staff...
BioCentury | Nov 15, 2004
Company News

Genstruct, Pfizer deal

...refining models for mechanism discovery and validation using gene expression, protein expression and proteomic data. Genstruct Inc....
BioCentury | Sep 20, 2004
Company News

Genstruct, Schering deal

...Inc. (Montville, N.J.) subsidiary. The companies hope to define the molecular causes of breast cancer. Genstruct Inc....
BioCentury | Sep 15, 2004
Company News

Genstruct, Berlex breast cancer model deal

Genstruct (Cambridge, Mass.) will use its Molecular Epistemics platform and Oncology Knowledge Assembly models to characterize breast cancer regulatory mechanisms for Berlex . The companies hope to define the molecular causes of breast cancer and to...
Items per page:
1 - 10 of 13
BioCentury | Feb 25, 2008
Company News

Genstruct, Pfizer deal

...Under a new a master research agreement with Pfizer, Genstruct will conduct a systems biology analysis...
...collaborated on more than 20 projects in cancer, vascular injury, cardiovascular diseases and metabolic diseases. Genstruct...
...biomarkers resulting from the master agreement, which covers prior collaborations. Financial terms were not disclosed. Genstruct Inc....
BioCentury | Jul 30, 2007
Company News

Genstruct management update

Genstruct Inc. , Cambridge, Mass Business: Combinatorial biology, Bioinformatics Hired: Christopher Thomajan as CFO, formerly CFO of Impress Software Inc.; he replaces Jim Melanson, who departed WIR Staff...
BioCentury | Apr 2, 2007
Company News

Genstruct management update

Genstruct Inc. , Cambridge, Mass. Business: Combinatorial biology, Bioinformatics Hired: Christian Reich as VP of scientific research, formerly a physician WIR Staff...
BioCentury | Aug 14, 2006
Company News

Genstruct, GlaxoSmithKline deal

...The companies extended for an undisclosed amount of time a 2005 deal in which Genstruct is...
...where the analysis will be extended into additional biological systems. Further terms were not disclosed. Genstruct Inc....
BioCentury | Aug 22, 2005
Company News

Genstruct, Pfizer deal

...Genstruct received an undisclosed first milestone payment from PFE under a 2004 deal to use Genstruct's...
...to identify biomarkers, improve leads and optimize clinical trial design (see BioCentury, Nov. 15, 2004). Genstruct Inc....
BioCentury | Jun 27, 2005
Company News

Genstruct scientific advisory board update

Genstruct Inc. , Cambridge, Mass. Business: Combinatorial biology, Bioinformatics Appointed: Alan Williamson, retired professor of biochemistry at the University of Glasgow WIR Staff...
BioCentury | Feb 21, 2005
Company News

Genstruct board of directors update

Genstruct Inc. , Cambridge, Mass. Business: Bioinformatics Appointed: Michael Pavia, former CTO of Millennium Pharmaceuticals Inc. WIR Staff...
BioCentury | Nov 15, 2004
Company News

Genstruct, Pfizer deal

...refining models for mechanism discovery and validation using gene expression, protein expression and proteomic data. Genstruct Inc....
BioCentury | Sep 20, 2004
Company News

Genstruct, Schering deal

...Inc. (Montville, N.J.) subsidiary. The companies hope to define the molecular causes of breast cancer. Genstruct Inc....
BioCentury | Sep 15, 2004
Company News

Genstruct, Berlex breast cancer model deal

Genstruct (Cambridge, Mass.) will use its Molecular Epistemics platform and Oncology Knowledge Assembly models to characterize breast cancer regulatory mechanisms for Berlex . The companies hope to define the molecular causes of breast cancer and to...
Items per page:
1 - 10 of 13